Estrogen receptor, p38 MAPKs and topo IIa in breast cancer

乳腺癌中的雌激素受体、p38 MAPK 和拓扑 IIa

• 批准号: 7789634
• 负责人: GUAN CHEN
• 金额: --
• 依托单位: CLEMENT J. ZABLOCKI VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2013-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7789634
• 关键词: Accounting; Attenuated; Binding; Breast Cancer Cell; Breast Cancer Model; Cancer Patient; Cell Culture Techniques; Cell Death; Country; Couples; DNA; DNA Topoisomerases; Disease; Doctor of Philosophy; Dominant-Negative Mutation; Drug toxicity; Engineering; Enrollment; Estrogen Receptor 2; Estrogen Receptors; Estrogen receptor negative; Estrogen receptor positive; Estrogens; Female; Funding; Gene Expression; Growth; Healthcare; Healthcare Systems; Human; In Vitro; JUN gene; Link; MAP Kinase Gene; MAPK14 gene; Malignant - descriptor; Malignant Neoplasms; Mediating; Medical; Military Personnel; Mus; Nude Mice; Paclitaxel; Pathway interactions; Patients; Pharmaceutical Preparations; Phosphorylation; Phosphotransferases; Protein Family; Proteins; Protocols documentation; Publishing; Receptor Cell; Receptor Signaling; Research; Research Personnel; Resistance; Role; Services; Signal Transduction; Stress; Tamoxifen; Testing; Therapeutic; Therapeutic Intervention; Topoisomerase; Topoisomerase II; Toxic effect; Toxin; Transactivation; Veterans; Woman; Work; arm; base; cancer therapy; cancer type; care systems; cellular targeting; chemotherapeutic agent; chemotherapy; drug sensitivity; hormone therapy; in vivo; inhibitor/antagonist; malignant breast neoplasm; multicatalytic endopeptidase complex; novel; novel therapeutics; protein expression; public health relevance; receptor expression; research study; response; therapeutic development; therapeutic target; tumor